Grifols Bio Supplies Inc.

Los Angeles, CA Part of Biomat Usa, Inc.

UEI
G2J3B2DKC4J2
CAGE
3J273
Primary NAICS
621991 Blood and Organ Banks
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
2410 Grifols Wy, Los Angeles, CA 90032, USA
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 -$1,578
FY2025 $30,870
FY2024 -$570

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Grifols Bio Supplies Inc. is a for-profit medical supplies company based in Los Angeles, California, registered in the System for Award Management (SAM.gov) since 2002, with a current registration valid through February 3, 2026. The company specializes in providing biological specimens and medical research materials, with a particular focus on supplying specialized blood products to federal research institutions. As a corporate entity, Grifols Bio Supplies Inc. has established itself as a reliable vendor for medical research organizations, demonstrating a consistent capability to fulfill precise biological product requirements.

The company has exclusively provided federal contract awards to the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. Its primary contract offerings have been highly specialized blood products, specifically O+ leuko-reduced ACD human packed red blood cells (RBCs) in varying quantities. These purchase order contracts range from $14,728.00 to $21,262.00, with completion dates between August 2022 and December 2025. Each contract has been a firm fixed-price purchase order without any set-aside designations, indicating open competition. The contracts consistently support NIAID's medical research programs by providing research-grade biological specimens, with recent orders including 36 units, 70 units, and 56 units of specific blood cell preparations. These precise, targeted contracts suggest Grifols Bio Supplies Inc. functions as a specialized biological materials supplier for advanced medical research purposes.

Quick answers

Is Grifols Bio Supplies Inc. registered in SAM.gov?

Yes. Grifols Bio Supplies Inc.'s SAM.gov registration is active through December 8, 2026.

How much has Grifols Bio Supplies Inc. received in federal contracts?

Federal contracts obligated $30,870 to Grifols Bio Supplies Inc. in fiscal year 2025 and $28,722 in fiscal years 2023 through 2027.

What is Grifols Bio Supplies Inc.'s most recent federal award?

Grifols Bio Supplies Inc.'s most recent federal contract award is 36 units of o+ leuko-reduced ACD human packed rbcs - varying units (ambis 2261278) (75N93025P01041), from National Institute of Allergy and Infectious Diseases (NIH), on July 1, 2025.

On GovTribe

See Grifols Bio Supplies Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors